The prevalence of anti-HCV antibodies in hemodialysis patients.
The prevalence of antibodies to hepatitis C virus (anti-HCV) was assessed in 489 hemodialysis patients and 152 members of the staff of dialysis units, using an Ortho HCV Ab ELISA Test. Of the 489 patients, 100 (20.4%) had anti-HCV, a significantly greater rate than was found in either staff members (0.7%, P less than 0.01) or local healthy blood donors (1.1%, P less than 0.001). Anti-HCV positivity was apparently related to the duration of hemodialysis.
Fujiyama
S
S
Third Department of Internal Medicine, Kumamoto University Medical School, Japan.
Kawano
S
S
Sato
S
S
Sato
T
T
Shimada
H
H
Matsushita
K
K
Hara
M
M
Ito
J
J
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006508:Hepatitis Antibodies / Q000097:blood*; D006526:Hepatitis C / Q000453:epidemiology / Q000209:etiology*; D006801:Humans; D007564:Japan / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D006435:Renal Dialysis / Q000009:adverse effects*; D016036:Seroepidemiologic Studies; D013997:Time Factors
D006508:Hepatitis Antibodies